85-1587-92 Xedar, Fc Chimera, Recombinant, Mouse, CF (Tumor Necrosis Factor Receptor Superfamily Member 27, X-linked Ectodysplasin-A2 Receptor, EDA-A2 Receptor, Tnfrsf27, EDA2R) 50ug X1011-52

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • X-linked Ectodysplasin Receptor (XEDAR), also known as EDA2R and TNFRSF27, is an ~45kD transmembrane protein in the TNF receptor superfamily. Mature mouse XEDAR consists of a 138aa extracellular domain (ECD) with three tandem TNFR cysteinerich domains, a 21aa transmembrane segment, and a 138aa cytoplasmic domain. Within the ECD, mouse XEDAR shares 87% and 96% aa sequence identity with human and rat XEDAR, respectively. A 20kD fragment of the ECD can be shed by metalloprotease mediated cleavage. XEDAR binds selectively to the EDAA2 variant of Ectodysplasin (EDA), while the closely related receptor EDAR binds selectively to the EDAA1 variant. Other than a 2aa deletion in its TNF-like-domain, EDAA2 is identical to EDAA1. Mutations in both EDAR and EDA are associated with hypohidrotic ectodermal dysplasia (HED), a disorder of hair, tooth, and eccrine sweat gland morphogenesis. XEDAR itself is strongly associated with androgenetic alopecia (male hair loss). XEDAR is widely expressed, notably in embryonic basal epidermal cells and maturing hair follicles. Even though it does not contain a cytoplasmic death domain, XEDAR can associate with Fas and induce EDAA2 dependent apoptosis. Its transcription is directly induced by p53, and XEDAR mediated cell death is p53 dependent. XEDAR is downregulated in breast, colon, and lung cancers, particularly in cases with p53 mutations. XEDAR also plays a role in EDAA2 induced skeletal muscle degeneration and osteoblast differentiation.
  • Source:Recombinant corresponding to aa1-138 mouse XEDAR expressed in NSO cell line.
  • Molecular Weight:~42.6kD
  • Endotoxin: ~1.0 EU/1ug (LAL)
  • Biological Activity:Measured by its binding ability in a functional ELISA. When recombinant mouse XEDAR Fc Chimera is coated at 0.1ug/ml (100ul/well), the concentration of recombinant human EDAA2 that produces 50% of the optimal binding response is typically 3-15ng/ml.
  • Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile buffer. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

  • Size:50ug
  • Source Antigen:Recombinant, NSO cells
  • Grade:Highly Purified
  • Purity:~95% (SDS-PAGE)
  • Form:Supplied as a lyophilized powder in PBS. Reconstitute with PBS to 100ug/ml.
  • Molecular Weight Non Ab:42.6
  • Swiss Prot Number:Q8BX35
  • EU Commodity Code:30021019
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-1587-92
型番
X1011-52
入り数
1個
標準価格
284,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る